NO20053775L - Diazepinoindol derivater som kinaseinhibitorer. - Google Patents

Diazepinoindol derivater som kinaseinhibitorer.

Info

Publication number
NO20053775L
NO20053775L NO20053775A NO20053775A NO20053775L NO 20053775 L NO20053775 L NO 20053775L NO 20053775 A NO20053775 A NO 20053775A NO 20053775 A NO20053775 A NO 20053775A NO 20053775 L NO20053775 L NO 20053775L
Authority
NO
Norway
Prior art keywords
kinase inhibitors
diazepinoindole
derivatives
compounds
diazepinoindole derivatives
Prior art date
Application number
NO20053775A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053775D0 (no
Inventor
Min Teng
Sacha Ninkovic
Michael John Bennett
Yuanjin Eugene Rui
Fen Wang
Suzanne Pritchett Benedict
Yong Wang
Jinjiang Zhu
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20053775D0 publication Critical patent/NO20053775D0/no
Publication of NO20053775L publication Critical patent/NO20053775L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20053775A 2003-01-09 2005-08-08 Diazepinoindol derivater som kinaseinhibitorer. NO20053775L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43939603P 2003-01-09 2003-01-09
PCT/IB2004/000026 WO2004063198A1 (en) 2003-01-09 2004-01-05 Diazepinoindole derivatives as kinase inhibitors

Publications (2)

Publication Number Publication Date
NO20053775D0 NO20053775D0 (no) 2005-08-08
NO20053775L true NO20053775L (no) 2005-09-16

Family

ID=32713475

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053775A NO20053775L (no) 2003-01-09 2005-08-08 Diazepinoindol derivater som kinaseinhibitorer.

Country Status (35)

Country Link
US (3) US6967198B2 (pl)
EP (2) EP1585749B1 (pl)
JP (1) JP3990718B2 (pl)
KR (1) KR100697746B1 (pl)
CN (1) CN1759118B (pl)
AP (1) AP2048A (pl)
AT (1) ATE404564T1 (pl)
AU (1) AU2004203977B2 (pl)
BR (1) BRPI0406701A (pl)
CA (1) CA2512683C (pl)
CR (1) CR7899A (pl)
CY (1) CY1108408T1 (pl)
DE (1) DE602004015724D1 (pl)
DK (1) DK1585749T3 (pl)
EA (1) EA009337B1 (pl)
EC (1) ECSP055911A (pl)
ES (1) ES2309484T3 (pl)
GE (1) GEP20084367B (pl)
HK (1) HK1086257A1 (pl)
HR (1) HRP20050624A2 (pl)
IL (1) IL169082A (pl)
IS (1) IS7884A (pl)
MA (1) MA27703A1 (pl)
MX (1) MXPA05007352A (pl)
NO (1) NO20053775L (pl)
NZ (1) NZ540638A (pl)
OA (1) OA13017A (pl)
PL (1) PL378372A1 (pl)
PT (1) PT1585749E (pl)
RS (1) RS20050522A (pl)
SI (1) SI1585749T1 (pl)
TN (1) TNSN05176A1 (pl)
UA (1) UA80733C2 (pl)
WO (1) WO2004063198A1 (pl)
ZA (1) ZA200504674B (pl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1467730A4 (en) * 2002-01-22 2010-03-10 Univ California Non-steroid ligands for the glucocorticoid receptor, compositions and uses thereof
ES2309484T3 (es) * 2003-01-09 2008-12-16 Pfizer Inc. Derivados de diazepinoindol como inhibidores de quinasa.
SI1853721T1 (sl) * 2005-02-18 2010-06-30 Astrazeneca Ab Postopek za ugotavljanje odzivnosti na CHK inhibitorje
NZ561458A (en) 2005-03-29 2011-03-31 Icos Corp Heteroaryl urea derivatives useful for inhibiting CHK1
GB0510390D0 (en) * 2005-05-20 2005-06-29 Novartis Ag Organic compounds
US8003625B2 (en) 2005-06-29 2011-08-23 Threshold Pharmaceuticals, Inc. Phosphoramidate alkylator prodrugs
WO2007022273A2 (en) 2005-08-15 2007-02-22 The Regents Of The University Of California Vegf-activated fas ligands
JP4935675B2 (ja) 2005-08-25 2012-05-23 宇部興産株式会社 光学活性（Ｓ又はＲ）−α−アミノ酸及び光学活性（Ｒ又はＳ）−α−アミノ酸エステルの製造方法
US7645885B2 (en) * 2005-08-26 2010-01-12 The Regents Of The University Of California Non-steroidal antiandrogens
EP2004655A1 (en) * 2006-04-04 2008-12-24 Pfizer Products Incorporated Polymorphic forms of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4 l)-1-oxo-2,6-dihydro-1h-ý1,2¨diazepinoý4,5,6-cd¨indol-8-yl)acetamide
CA2648371A1 (en) * 2006-04-04 2007-10-11 Pfizer Products Inc. Combination therapy of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4-yl)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide
JP2010510222A (ja) * 2006-11-17 2010-04-02 シェーリング コーポレイション 増殖性障害に対する併用療法
US8158656B2 (en) * 2008-05-16 2012-04-17 Shenzhen Chipscreen Biosciences Ltd. 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
WO2010016005A1 (en) * 2008-08-06 2010-02-11 Pfizer Inc. 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
WO2010040527A1 (en) * 2008-10-10 2010-04-15 Priaxon Ag Novel compounds which modulate kinase activity
US8314108B2 (en) 2008-12-17 2012-11-20 Eli Lilly And Company 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts
US8663210B2 (en) 2009-05-13 2014-03-04 Novian Health, Inc. Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy
US8211901B2 (en) 2009-05-22 2012-07-03 Shenzhen Chipscreen Biosciences Ltd. Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
CN101906076B (zh) 2009-06-04 2013-03-13 深圳微芯生物科技有限责任公司 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
US9187494B2 (en) 2011-05-06 2015-11-17 Zafgen, Inc. Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators
EP2793882A4 (en) 2011-12-22 2015-04-29 Threshold Pharmaceuticals Inc ADMINISTRATION OF HYPOXIA ACTIVATED DRUGS IN COMBINATION WITH CHK1 INHIBITORS FOR THE TREATMENT OF CANCER
PT2797921T (pt) * 2011-12-31 2017-11-14 Beigene Ltd Dihidrodiazepinocarbazolonas tetra ou pentacíclicas fundidas como inibidoras de parp
CN106083849A (zh) 2011-12-31 2016-11-09 百济神州有限公司 作为parp抑制剂的稠合的四元或五元环吡啶并酞嗪酮类化合物
CN102746211B (zh) * 2012-06-27 2015-05-27 上海泰坦化学有限公司 一种取代吲哚-3-甲醛类化合物的制备方法
TWI633107B (zh) * 2013-05-22 2018-08-21 開曼群島商百濟神州生物科技有限公司 作為ｐａｒｐ抑制劑的稠合四或五環二氫二氮呯并咔唑酮
KR20160099081A (ko) 2013-07-26 2016-08-19 업데이트 파마 인코포레이트 비산트렌의 치료 효과 개선용 조합 방법
US10071109B2 (en) 2013-11-06 2018-09-11 Molecular Templates, Inc. Predictive biomarker for hypoxia-activated prodrug therapy
ES2733847T3 (es) 2014-06-17 2019-12-03 Vertex Pharma Método para tratar cáncer usando una combinación de inhibidores de CHK1 y ATR
KR20180041748A (ko) * 2015-08-25 2018-04-24 베이진 엘티디 Parp 억제제, 결정형의 제조방법 및 이의 용도
WO2017059357A1 (en) 2015-09-30 2017-04-06 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of dna damaging agents and atr inhibitors
CN110087730B (zh) 2016-09-27 2023-03-28 百济神州(苏州)生物科技有限公司 使用包含parp抑制剂的组合产品治疗癌症
JP6541635B2 (ja) * 2016-10-28 2019-07-10 ベイジーン リミテッド Ｐａｒｐ阻害剤としての縮合四環式または縮合五環式ジヒドロジアゼピノカルバゾロン
US10899763B2 (en) 2017-02-28 2021-01-26 Beigene, Ltd. Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereof
US11661581B2 (en) * 2017-05-25 2023-05-30 University Of Massachusetts Use of CDK inhibitors to enhance growth and self-renewal of progenitor cells
CN111108105B (zh) * 2017-09-22 2023-03-31 朱比兰特埃皮帕德有限公司 作为pad抑制剂的杂环化合物
EP3461480A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
CN113631179A (zh) * 2019-01-25 2021-11-09 努梅迪公司 用于治疗特发性肺纤维化的方法
CN114072410B (zh) * 2019-08-01 2023-08-01 正大天晴药业集团股份有限公司 作为parp抑制剂吲哚并七元酰肟化合物
CN114746413B (zh) 2019-11-29 2024-02-23 南京明德新药研发有限公司 二氮杂吲哚类衍生物及其作为Chk1抑制剂的应用
CA3184988A1 (en) * 2020-07-13 2022-01-20 Ahmed Mamai Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof
AU2021318572A1 (en) * 2020-07-31 2023-02-16 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Indolo heptamyl oxime analog crystal as PARP inhibitor and method for preparing same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722320D0 (en) 1997-10-22 1997-12-17 Janssen Pharmaceutica Nv Human cell cycle checkpoint proteins
US6383744B1 (en) 1998-07-10 2002-05-07 Incyte Genomics, Inc. Human checkpoint kinase
JP2002526450A (ja) 1998-09-18 2002-08-20 スミスクライン・ビーチャム・コーポレイション Ｃｈｋ１キナーゼ阻害物質
HU229875B1 (en) 1999-01-11 2014-11-28 Agouron Pharmaceuticals Inc La Jolla Tricyclic inhibitors of poly(adp-ribose) polymerases
ATE388226T1 (de) 1999-08-27 2008-03-15 Novartis Vaccines & Diagnostic Chimerische antisense-oligonukleotide und zelltransfektions-zusammensetzungen davon
ECSP003637A (es) 1999-08-31 2002-03-25 Agouron Pharma Inhibidores triciclicos de poli (adp-ribosa) polimerasas
US6670167B1 (en) 1999-11-01 2003-12-30 Agouron Pharmaceuticals, Inc. Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof
ES2239037T3 (es) 1999-09-22 2005-09-16 Canbas Co., Ltd. Metodos y composiciones para inhibir la deteccion del ciclo celular en g2 y sensibilizar celulas a agentes dañinos del dna.
US6211164B1 (en) 2000-03-10 2001-04-03 Abbott Laboratories Antisense oligonucleotides of the human chk1 gene and uses thereof
JP4323802B2 (ja) * 2000-12-01 2009-09-02 エムジーアイ・ジーピー・インコーポレーテッド 化合物およびその使用
UA76977C2 (en) 2001-03-02 2006-10-16 Icos Corp Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
ES2309484T3 (es) * 2003-01-09 2008-12-16 Pfizer Inc. Derivados de diazepinoindol como inhibidores de quinasa.

Also Published As

Publication number Publication date
KR20050092397A (ko) 2005-09-21
ATE404564T1 (de) 2008-08-15
EA200500893A1 (ru) 2006-02-24
RS20050522A (en) 2007-12-31
WO2004063198A1 (en) 2004-07-29
EP1947102A1 (en) 2008-07-23
BRPI0406701A (pt) 2005-12-20
DE602004015724D1 (de) 2008-09-25
CA2512683C (en) 2010-03-16
CR7899A (es) 2005-08-05
DK1585749T3 (da) 2008-09-22
US20050075499A1 (en) 2005-04-07
AU2004203977B2 (en) 2010-06-17
JP2006516274A (ja) 2006-06-29
HK1086257A1 (en) 2006-09-15
AP2005003353A0 (en) 2005-09-30
AU2004203977A1 (en) 2004-07-29
EP1585749B1 (en) 2008-08-13
GEP20084367B (en) 2008-05-13
OA13017A (en) 2006-11-10
ZA200504674B (en) 2006-07-26
NZ540638A (en) 2007-12-21
MA27703A1 (fr) 2006-01-02
US7462713B2 (en) 2008-12-09
CA2512683A1 (en) 2004-07-29
PL378372A1 (pl) 2006-04-03
IL169082A (en) 2011-02-28
MXPA05007352A (es) 2006-02-17
TNSN05176A1 (fr) 2007-06-11
UA80733C2 (en) 2007-10-25
HRP20050624A2 (en) 2006-02-28
ES2309484T3 (es) 2008-12-16
JP3990718B2 (ja) 2007-10-17
SI1585749T1 (sl) 2008-10-31
KR100697746B1 (ko) 2007-03-22
US6967198B2 (en) 2005-11-22
CY1108408T1 (el) 2014-02-12
EA009337B1 (ru) 2007-12-28
CN1759118B (zh) 2010-12-08
US20060004052A1 (en) 2006-01-05
NO20053775D0 (no) 2005-08-08
IS7884A (is) 2005-06-09
AP2048A (en) 2009-09-24
ECSP055911A (es) 2005-11-22
US20070135415A1 (en) 2007-06-14
PT1585749E (pt) 2008-10-23
US7132533B2 (en) 2006-11-07
CN1759118A (zh) 2006-04-12
EP1585749A1 (en) 2005-10-19

Similar Documents

Publication Publication Date Title
NO20053775L (no) Diazepinoindol derivater som kinaseinhibitorer.
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
NO20092737L (no) Substituerte pyrazolo-kinazolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som kinase-inhibitorer
BRPI0515991A (pt) derivados de bisariluréia substituìda heterocìclica como inibidores de cinase
NO20061746L (no) Kinazolinderivater som antiproliferative midler
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
ATE456565T1 (de) Pyridin- und pyrazinderivate als mnk- kinaseinhibitoren
NO20076460L (no) Nye fluorenderivater, sammensetninger inneholdende nevnte derivater og anvendelse derav
NO20060415L (no) Piperidyl-Kinazolinderivater som Tyrosin-Kinase-Inhibitorer
CY1112084T1 (el) Παραγωγα 5-φαινυλθειαζολης και χρηση ως αναστολεις της κινασης ρi3
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
NO20061743L (no) Kinazolinderivater
NO20090631L (no) Morpholin pyrimidin derivativer anvendelige i behandlingen av proliferative lidelser
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
NO20084496L (no) Pyridyl- og pyrimidinylsubstituerte pyrrol-, tiofen- og furanderivater som kinaseinhibitorer
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
DK1636236T3 (da) Pyrazolo-quinazolin-derivater, en fremgangsmåde til fremstilling deraf, og deres anvendelse som kinase-inhibitorer
BRPI0408068A (pt) derivados de 5-feniltiazol e seus usos como inibidores de pi3 cinase
NO20061506L (no) Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
NO20055891L (no) Kinazolinderivater som aurorakinaseinhibitorer
DK2324008T3 (da) Diarylpyrazol som protein kinase inhibitorer
ECSP067076A (es) Derivados de pirimidina urea como inhibidores de la quinasa
NO20082730L (no) Morfolinopyrimidinderivater og deres anvendelse i terapi